Applied Dna Sciences Inc EBITDA margin
¿Qué es el EBITDA margin de Applied Dna Sciences Inc?
El EBITDA margin de Applied Dna Sciences Inc es -452.18%
¿Cuál es la definición de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de compañías en Sector Industrials en NASDAQ en comparadas con Applied Dna Sciences Inc
¿Qué hace Applied Dna Sciences Inc?
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Empresas con ebitda margin similar a Applied Dna Sciences Inc
- Eiger BioPharmaceuticals Inc tiene EBITDA margin de -453.38%
- Desert Mountain tiene EBITDA margin de -452.99%
- Macrogenics Inc tiene EBITDA margin de -452.96%
- RevoluGROUP Canada tiene EBITDA margin de -452.79%
- Atlantic Sapphire ASA tiene EBITDA margin de -452.71%
- Heartsoft tiene EBITDA margin de -452.66%
- Applied Dna Sciences Inc tiene EBITDA margin de -452.18%
- NeuroScientific Biopharmaceuticals tiene EBITDA margin de -451.90%
- Hammer Metals tiene EBITDA margin de -450.60%
- Musgrave Minerals tiene EBITDA margin de -448.62%
- Eargo tiene EBITDA margin de -447.64%
- Selecta Biosciences Inc tiene EBITDA margin de -446.27%
- Queste Communications Ltd tiene EBITDA margin de -445.98%